Full Text View
Tabular View
No Study Results Posted
Related Studies
Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population (CAPABLE)
This study has been completed.
Study NCT00150384   Information provided by Pfizer
First Received: September 6, 2005   Last Updated: April 17, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
Dyslipidemia
Additional conditions recognized in this trial
Dyslipidemias
More general conditions related to this trial
Cardiovascular Diseases
Lipid Metabolism Disorders
Metabolic Diseases
Vascular Diseases
Interventions listed in this trial
Amlodipine/Atorvastatin
Additional drug interventions recognized in this trial
Amlodipine
Atorvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antihypertensive Agents
Antilipemic Agents
Antimetabolites
Calcium Channel Blockers
Cardiovascular Agents
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services